BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 18, 2026
Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 25, 2002
By Cormac Sheridan

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 24, 2002
By Cormac Sheridan

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 24, 2002
By Cormac Sheridan

Actelion Moving Tezosentan Into Phase III For Acute Heart Failure

Sep. 18, 2002
By Cormac Sheridan

Lund University Establishing Stem Cell Research Institute

Sep. 18, 2002
By Cormac Sheridan

GPCRs Focus Of Deals Involving Biovitrium, BioFocus, BioXell

Sep. 18, 2002
By Cormac Sheridan
G protein-coupled receptors, the superfamily of membrane-spanning proteins involved in diverse signaling processes, are the subject of two drug discovery collaborations unveiled last week by European biotechnology firms. (BioWorld International)
Read More

Lund University Establishing Stem Cell Research Institute

Sep. 18, 2002
By Cormac Sheridan

GPCRs Focus Of Deals Involving Biovitrium, BioFocus, BioXell

Sep. 18, 2002
By Cormac Sheridan
G protein-coupled receptors, the superfamily of membrane-spanning proteins involved in diverse signaling processes, are the subject of two drug discovery collaborations unveiled last week by European biotechnology firms. (BioWorld International)
Read More

Actelion Moving Tezosentan Into Phase III For Acute Heart Failure

Sep. 18, 2002
By Cormac Sheridan

Medivir To Lose CEO Frick To Venture Capital Fund

Sep. 11, 2002
By Cormac Sheridan
View All Articles by Cormac Sheridan

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing